Strand V - Search Results

1

Improvements in health-related quality of life with belimumab, a B-lymphocyte stimulator-specific inhibitor, in patients with autoantibody-positive systemic lupus erythematosus from the randomised controlled BLISS trials.

Strand V, Levy RA, Cervera R, Petri MA, Birch H, Freimuth WW, Zhong ZJ, Clarke AE; BLISS-52 and -76 Study Groups. Strand V, et al. Ann Rheum Dis. 2014 May;73(5):838-44. doi: 10.1136/annrheumdis-2012-202865. Epub 2013 Mar 22. Ann Rheum Dis. 2014. PMID: 23524886 Free PMC article. Clinical Trial.

2

Outcome measures to be used in clinical trials in systemic lupus erythematosus.

Strand V, Gladman D, Isenberg D, Petri M, Smolen J, Tugwell P. Strand V, et al. J Rheumatol. 1999 Feb;26(2):490-7. J Rheumatol. 1999. PMID: 9972993

3

Randomized clinical trials and longitudinal observational studies in systemic lupus erythematosus: consensus on a preliminary core set of outcome domains.

Smolen JS, Strand V, Cardiel M, Edworthy S, Furst D, Gladman D, Gordon C, Isenberg DA, Klippel JH, Petri M, Simon L, Tugwell P, Wolfe F. Smolen JS, et al. Among authors: strand v. J Rheumatol. 1999 Feb;26(2):504-7. J Rheumatol. 1999. PMID: 9972996

4

Biologic agents and innovative interventional approaches in the management of systemic lupus erythematosus.

Strand V. Strand V. Curr Opin Rheumatol. 1999 Sep;11(5):330-40. doi: 10.1097/00002281-199909000-00002. Curr Opin Rheumatol. 1999. PMID: 10503651 Review.

5

New therapies for systemic lupus erythematosus.

Strand V. Strand V. Rheum Dis Clin North Am. 2000 May;26(2):389-406, viii. doi: 10.1016/s0889-857x(05)70145-9. Rheum Dis Clin North Am. 2000. PMID: 10768219 Review.

6

Endpoints: consensus recommendations from OMERACT IV. Outcome Measures in Rheumatology.

Strand V, Gladman D, Isenberg D, Petri M, Smolen J, Tugwell P. Strand V, et al. Lupus. 2000;9(5):322-7. doi: 10.1191/096120300678828424. Lupus. 2000. PMID: 10878722 Review.

7

Effects of prasterone on corticosteroid requirements of women with systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial.

Petri MA, Lahita RG, Van Vollenhoven RF, Merrill JT, Schiff M, Ginzler EM, Strand V, Kunz A, Gorelick KJ, Schwartz KE; GL601 Study Group. Petri MA, et al. Among authors: strand v. Arthritis Rheum. 2002 Jul;46(7):1820-9. doi: 10.1002/art.10364. Arthritis Rheum. 2002. PMID: 12124866 Free article. Clinical Trial.

8

Using estimated yearly progression rates to compare radiographic data across recent randomised controlled trials in rheumatoid arthritis.

Strand V, Landéwé R, van der Heijde D. Strand V, et al. Ann Rheum Dis. 2002 Nov;61 Suppl 2(Suppl 2):ii64-6. doi: 10.1136/ard.61.suppl_2.ii64. Ann Rheum Dis. 2002. PMID: 12379626 Free PMC article. Review. No abstract available.

9

Improvement in health-related quality of life in systemic lupus erythematosus patients enrolled in a randomized clinical trial comparing LJP 394 treatment with placebo.

Strand V, Aranow C, Cardiel MH, Alarcón-Segovia D, Furie R, Sherrer Y, Tumlin J, Wallace DJ, Crawford B; LJP 394 Investigator Consortium. Strand V, et al. Lupus. 2003;12(9):677-86. doi: 10.1191/0961203303lu440oa. Lupus. 2003. PMID: 14514130 Clinical Trial.

10

Long term evaluation of radiographic disease progression in a subset of patients with rheumatoid arthritis treated with leflunomide beyond 2 years.

van der Heijde D, Kalden J, Scott D, Smolen J, Strand V. van der Heijde D, et al. Among authors: strand v. Ann Rheum Dis. 2004 Jun;63(6):737-9. doi: 10.1136/ard.2003.010983. Ann Rheum Dis. 2004. PMID: 15140783 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

535 results

Search Page

Filters